Brad previously ran DIC Entertainment as President for 6 years after working for Donaldson, Lufkin, and Jenrette as an Investment Banker. After acquiring the company with Bain Capital from the Walt Disney Company in 2000, he helped grow the company from less than $10mm of revenues to over $80mm in 2005 when he took the company public on the London Stock Exchange at a $200mm valuation. Brad received his BA from UC Berkeley and an MBA from the University of Chicago.
Dr. Andrew A. Brooks, founded Cardo Medical, Inc. in May 2007 which was acquired by Arthrex in 2011. Dr. Brooks has been in the private practice of orthopedic surgery since 1994, specializing in sports medicine, arthroscopy and joint reconstruction. Prior to founding Cardo Medical, founded Specialty Surgical Center, and sold it to Symbion (NASDAQ; SMBI) in 2005. Dr. Brooks is board-certified by the American Board of Orthopedic Surgery and is a Fellow of the American Academy of Orthopedic Surgeons. He received his B.S. and M.D. degrees from University of Southern California. He completed his Residency in Orthopedic Surgery at the University of Southern California, and subsequently completed a fellowship in arthroscopic reconstructive surgery and sports medicine at the Hughston Clinic in Columbus, Georgia.
Vijay Lathi is Managing Director at New Leaf Ventures and concentrates primarily on our information convergence and diagnostics investments. Vijay joined Sprout in 1998, and was part of the team that spun out of Sprout in 2005 to form New Leaf. Prior to joining Sprout, working as an analyst in the Healthcare Venture Capital Group at Robertson Stephens & Co. and Cornerstone Research, a consulting firm focused on financial and economic analysis for business litigation. Vijay graduated from the Massachusetts Institute of Technology and Stanford University where he received his B.S. and M.S. in Chemical Engineering, with an emphasis on the application of engineering to life science technology. Vijay is also a member of AiCHE.
Dr. Matly is a Managing Director at Montreux Growth Partners (MGP) leading late-stage investments in health services and technology companies. He currently serves on the boards of Tiger Connect, Kareo, Pure Life Renal, and Pulmonx. He also led and represented MGP on the board of MINDBODY Online (NASDAQ: MB).
Before joining MGP, Dr. Matly led Business Development and New Ventures at the Mayo Clinic Center for Innovation. Dr. Matly’s responsibilities included new venture incubation, new product development for Mayo Clinic’s consumer offerings, and strategic initiatives between Mayo Clinic and Fortune 100 companies from the retail, consumer, payer, technology, communications, and food/nutrition sectors.
Dr. Matly is a founding advisor to Rock Health, a leading digital health incubator based in San Francisco. He also serves as a Board Director for the Order of Malta Clinic in Oakland, California.
Dr. Matly completed his M.D. from the Mayo Clinic, M.B.A. from Harvard Business School, and B.S. from Cornell University.
Robert Mittendorff, M.D., focuses on investing capital in venture and growth opportunities in the healthcare sector. He is an active board-certified emergency physician and former operating executive (Hansen Medical / Robotics) with experience that spans investing, complex business development transactions, the leadership of clinical advisory boards, product development, clinical trials, commercial activities, and clinical services management.
At Norwest Venture Partners he focuses on investing in category-defining companies led by exceptional management teams. He currently serves on the boards of Impel Neuropharma, Qventus, Silk Road Medical, TigerConnect, and VisitPay, and is a board observer at Talkspace and Omada Health. He was a board member at iCardiac (acquired by eResearch), Telcare (acquired by BioTelemetry) and was a board observer at Crossover Health (acquired by Gurnet). Dr. Mittendorff was a previous board observer at Intersect ENT (Nasdaq: XENT), and iRhythm Technologies (Nasdaq: IRTC). Dr. Mittendorff was involved with the initial investments in Misfit Wearables (acquired by Fossil) and Health Catalyst.
He is a Harvard/Stanford-trained emergency physician who received his medical doctorate and master of business administration degrees from Harvard and has prior experience at Merck and the Boston Consulting Group. He received his bachelor of science degree in biomedical engineering from Johns Hopkins University.
Perry Wallack, co-founder and CFO of Cornerstone OnDemand, is responsible for the Company’s accounting, tax and financial functions, systems and processes. With over 20 years of experience in finance, accounting, tax and operations, Wallack has a wealth of expertise in several strategic financial disciplines, including financial planning, taxation, auditing and accounting for both public and private companies. Wallack has successfully raised public equity, private equity and commercial bank financing with Cornerstone since November 1999. Wallack was a driving force behind Cornerstone’s successful IPO in 2011. As a founder of Cornerstone, Wallack has gained the invaluable experience of growing the business from inception in 1999 to the present day scale of an organization with over 600 employees.
Steven Yecies, is a Venture Partner at OrbiMed. Mr. Yecies brings over 20 years of experience as an investor, consultant, entrepreneur and senior manager in the healthcare information technology and healthcare services sectors. Most recently, he founded and ran Chronic Health Capital and serves on the Board of Dicom Grid and as an advisor to integrated health systems. Mr. Yecies founded and operated the global health and wellness business at Scient (Nasdaq: SCNT) where he built several first generation e-health businesses. Mr. Yecies holds an M.B.A. from Harvard Business School, a J.D. from U.C. Berkeley Law School and received his A.B. in Government from Dartmouth College.
Garheng Kong founded HealthQuest Capital in 2012 to improve people’s lives through improving healthcare on a significant scale. A physician, scientist, and engineer by training, Garheng has over two decades of experience investing in innovative healthcare companies with a long list of successes (25 IPO/M&A exits). He has represented HealthQuest on the boards of Ajax I, Ajax II, Ajax III, Alcresta, Avedro, Avizia, BardyDx, Castle Biosciences, CleanSlate, Etairos, ENT Specialty Partners, Everlywell, HealthChannels, Magnolia Medical, Perspectum, Pulmonx, Spirox, TigerConnect, Trice Medical, Venus Concept, and CareMetx/VirMedica. Garheng received undergraduate degrees in both Chemical Engineering and Biological Sciences from Stanford, while on an athletic scholarship. He then earned an MD, Ph.D., and MBA from Duke University, graduating at the top of his class in each instance. He is married to his physician wife (a board-certified cardiac electrophysiologist), has 3 children, and was a nationally ranked volleyball player (and avid “foodie”).